This finding was supported by the European Medicines Agency and the Food and Drug Administration, which jointly conducted a comprehensive analysis of toxicology studies, revealing that they are less prone to pancreatitis following GLP-1 RA [29]. This evidence concerns the gene GLP1R and pancreatitis.